Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin

dc.contributor.authorGqada Z.
dc.contributor.authorMarais B.
dc.contributor.authorWasserman E.
dc.contributor.authorBamford C.
dc.contributor.authorOrth H.
dc.date.accessioned2011-05-15T16:16:55Z
dc.date.available2011-05-15T16:16:55Z
dc.date.issued2008
dc.description.abstract[No abstract available]
dc.description.versionLetter
dc.identifier.citationJournal of Clinical Microbiology
dc.identifier.citation46
dc.identifier.citation7
dc.identifier.issn00951137
dc.identifier.other10.1128/JCM.00519-08
dc.identifier.urihttp://hdl.handle.net/10019.1/13992
dc.subjectdaptomycin
dc.subjectflucloxacillin
dc.subjectlevofloxacin
dc.subjectnafcillin
dc.subjectoxacillin
dc.subjectvancomycin
dc.subjectantiinfective agent
dc.subjectantibiotic sensitivity
dc.subjectbacteremia
dc.subjectdrug efficacy
dc.subjectdrug exposure
dc.subjectdrug substitution
dc.subjectendocarditis
dc.subjecthuman
dc.subjectletter
dc.subjectmethicillin susceptible Staphylococcus aureus
dc.subjectmonotherapy
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectStaphylococcus aureus
dc.subjecttreatment response
dc.subjectadult
dc.subjectantibiotic resistance
dc.subjectbacterial endocarditis
dc.subjectdrug effect
dc.subjectisolation and purification
dc.subjectmicrobiology
dc.subjectnote
dc.subjectStaphylococcus infection
dc.subjectStaphylococcus aureus
dc.subjectAdult
dc.subjectAnti-Bacterial Agents
dc.subjectDaptomycin
dc.subjectDrug Resistance, Bacterial
dc.subjectEndocarditis, Bacterial
dc.subjectHumans
dc.subjectStaphylococcal Infections
dc.subjectStaphylococcus aureus
dc.titleClinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin
dc.typeLetter
Files